US Physical Therapy Inc (USPH, Financial) files its latest 10-K with SEC for the fiscal year ended on December 31, 2017. US Physical Therapy Inc operates outpatient physical therapy and occupational therapy clinics across US which provide treatment for orthopedic disorders, sports-related injuries, and work-related injuries. US Physical Therapy Inc has a market cap of $1.05 billion; its shares were traded at around $83.55 with a P/E ratio of 47.73 and P/S ratio of 2.54. The dividend yield of US Physical Therapy Inc stocks is 0.96%. US Physical Therapy Inc had annual average EBITDA growth of 9.50% over the past ten years. GuruFocus rated US Physical Therapy Inc the business predictability rank of 4.5-star.
For the last quarter US Physical Therapy Inc reported a revenue of $109.2 million, compared with the revenue of $90.86 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $414.1 million, an increase of 16.1% from last year. For the last five years US Physical Therapy Inc had an average revenue growth rate of 10.6% a year.
The reported diluted earnings per share was $1.76 for the year, an increase of 7.3% from previous year. Over the last five years US Physical Therapy Inc had an EPS growth rate of 6.4% a year. The US Physical Therapy Inc had a decent operating margin of 13.22%, compared with the operating margin of 13.89% a year before. The 10-year historical median operating margin of US Physical Therapy Inc is 14.16%. The profitability rank of the company is 7 (out of 10).
At the end of the fiscal year, US Physical Therapy Inc has the cash and cash equivalents of $21.9 million, compared with $20.0 million in the previous year. The long term debt was $56.7 million, compared with $50.6 million in the previous year. The interest coverage to the debt is 2.6, which is not a favorable level. US Physical Therapy Inc has a financial strength rank of 6 (out of 10).
At the current stock price of $83.55, US Physical Therapy Inc is traded at 98.2% premium to its historical median P/S valuation band of $42.16. The P/S ratio of the stock is 2.54, while the historical median P/S ratio is 1.28. The intrinsic value of the stock is $23.13 a share, according to GuruFocus DCF Calculator. The stock gained 15.69% during the past 12 months.
CEO Recent Trades:
- CEO Christopher J Reading sold 12,000 shares of USPH stock on 03/09/2018 at the average price of $86.57. The price of the stock has decreased by 3.49% since.
CFO Recent Trades:
- CFO Lawrance W Mcafee sold 2,000 shares of USPH stock on 03/12/2018 at the average price of $86.06. The price of the stock has decreased by 2.92% since.
- CFO Lawrance W Mcafee sold 5,000 shares of USPH stock on 03/09/2018 at the average price of $83.35. The price of the stock has increased by 0.24% since.
Directors and Officers Recent Trades:
- Director Bernard A Harris Jr sold 6,000 shares of USPH stock on 03/12/2018 at the average price of $86.53. The price of the stock has decreased by 3.44% since.
- Director Jerald L Pullins sold 6,100 shares of USPH stock on 03/09/2018 at the average price of $86.54. The price of the stock has decreased by 3.46% since.
For the complete 20-year historical financial data of USPH, click here.
